Skip to main content
Erschienen in: World Journal of Urology 3/2011

01.06.2011 | Topic Paper

Health services research in urology

verfasst von: Hua-yin Yu, William Ulmer, Keith J. Kowalczyk, Jim C. Hu

Erschienen in: World Journal of Urology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Health services research (HSR) is increasingly important given the focus on patient-centered, cost-effective, high-quality health care. We examine how HSR affects contemporary evidence-based urologic practice and its role in shaping future urologic research and care.

Methods

PubMed, urologic texts, and lay literature were reviewed for terms pertaining to HSR/outcomes research and urologic disease processes.

Results

HSR is a broad discipline that focuses on access, cost, and outcomes of Health care. Its use has been applied to a myriad of urologic conditions to identify deficiencies in access, to evaluate cost-effectiveness of therapies, and to evaluate structural, process, and outcome quality measures.

Conclusions

HSR utilizes an evidence-based approach to identify the most effective ways to organize/manage, finance, and deliver high-quality urologic care and to tailor care optimized to individuals.
Literatur
2.
Zurück zum Zitat Litwin MS (2007) Outcomes research. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell-Walsh urology, 9th edn. Elsevier, Amsterdam, pp 144–158 Litwin MS (2007) Outcomes research. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell-Walsh urology, 9th edn. Elsevier, Amsterdam, pp 144–158
3.
Zurück zum Zitat Kelley E, Moy E, Dayton E (2005) Health care quality and disparities: lessons from the first national reports. Med Care 43(Suppl 3):I1–I2PubMed Kelley E, Moy E, Dayton E (2005) Health care quality and disparities: lessons from the first national reports. Med Care 43(Suppl 3):I1–I2PubMed
4.
Zurück zum Zitat Kelley E, Moy E, Stryer D, Burstin H, Clancy C (2005) The national healthcare quality and disparities reports: an overview. Med Care 43(Suppl 3):I3–I8PubMed Kelley E, Moy E, Stryer D, Burstin H, Clancy C (2005) The national healthcare quality and disparities reports: an overview. Med Care 43(Suppl 3):I3–I8PubMed
5.
Zurück zum Zitat Aday LA, Andersen RM (1981) Equity of access to medical care: a conceptual and empirical overview. Med Care 19(12):4–27CrossRef Aday LA, Andersen RM (1981) Equity of access to medical care: a conceptual and empirical overview. Med Care 19(12):4–27CrossRef
8.
Zurück zum Zitat Demark-Wahnefried W, Strigo T, Catoe K, Conaway M, Brunetti M, Rimer BK, Robertson CN (1995) Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening. Urology 46(3):346–351PubMedCrossRef Demark-Wahnefried W, Strigo T, Catoe K, Conaway M, Brunetti M, Rimer BK, Robertson CN (1995) Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening. Urology 46(3):346–351PubMedCrossRef
9.
Zurück zum Zitat Jayadevappa R, Chhatre S, Johnson JC, Malkowicz SB (2010) Variation in quality of care among older men with localized prostate cancer. Cancer [Epub ahead of print] Jayadevappa R, Chhatre S, Johnson JC, Malkowicz SB (2010) Variation in quality of care among older men with localized prostate cancer. Cancer [Epub ahead of print]
10.
Zurück zum Zitat Fitzpatrick P, Corcoran N, Fitzpatrick JM (1998) Prostate cancer: how aware is the public? Br J Urol 82(1):43–48PubMed Fitzpatrick P, Corcoran N, Fitzpatrick JM (1998) Prostate cancer: how aware is the public? Br J Urol 82(1):43–48PubMed
11.
Zurück zum Zitat de Wit R, Fizazi K (2006) Controversies in the management of clinical stage I testis cancer. J Clin Oncol 24(35):5482–5492PubMedCrossRef de Wit R, Fizazi K (2006) Controversies in the management of clinical stage I testis cancer. J Clin Oncol 24(35):5482–5492PubMedCrossRef
12.
Zurück zum Zitat Routh JC, Grant FD, Kokorowski P, Lee RS, Fahey FH, Treves ST, Nelson CP (2010) Costs and consequences of universal sibling screening for vesicoureteral reflux: decision analysis. Pediatrics 126(5):865–871PubMedCrossRef Routh JC, Grant FD, Kokorowski P, Lee RS, Fahey FH, Treves ST, Nelson CP (2010) Costs and consequences of universal sibling screening for vesicoureteral reflux: decision analysis. Pediatrics 126(5):865–871PubMedCrossRef
13.
Zurück zum Zitat Donabedian A (1966) Evaluating the quality of medical care. Milbank Mem Fund Q 44(Suppl 3):166–206PubMedCrossRef Donabedian A (1966) Evaluating the quality of medical care. Milbank Mem Fund Q 44(Suppl 3):166–206PubMedCrossRef
14.
Zurück zum Zitat Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346(15):1128–1137PubMedCrossRef Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346(15):1128–1137PubMedCrossRef
15.
Zurück zum Zitat Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349(22):2117–2127PubMedCrossRef Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349(22):2117–2127PubMedCrossRef
16.
Zurück zum Zitat Hu JC, Gold KF, Pashos CL, Mehta SS, Litwin MS (2003) Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol 21(3):401–405PubMedCrossRef Hu JC, Gold KF, Pashos CL, Mehta SS, Litwin MS (2003) Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol 21(3):401–405PubMedCrossRef
17.
Zurück zum Zitat Semel ME, Resch S, Haynes AB, Funk LM, Bader A, Berry WR, Weiser TG, Gawande AA (2010) Adopting a surgical safety checklist could save money and improve the quality of care in US hospitals. Health Aff 29(9):1593–1599CrossRef Semel ME, Resch S, Haynes AB, Funk LM, Bader A, Berry WR, Weiser TG, Gawande AA (2010) Adopting a surgical safety checklist could save money and improve the quality of care in US hospitals. Health Aff 29(9):1593–1599CrossRef
18.
Zurück zum Zitat Weiser TG, Haynes AB, Lashoher A, Dziekan G, Boorman DJ, Berry WR, Gawande AA (2010) Perspectives in quality: designing the WHO Surgical Safety Checklist. Int J Qual Health Care 22(5):365–370PubMedCrossRef Weiser TG, Haynes AB, Lashoher A, Dziekan G, Boorman DJ, Berry WR, Gawande AA (2010) Perspectives in quality: designing the WHO Surgical Safety Checklist. Int J Qual Health Care 22(5):365–370PubMedCrossRef
20.
Zurück zum Zitat Hanchanale VS, Javle P (2010) Impact of hospital provider volume on outcome for radical urological cancer surgery in England. Urol Int 85(1):11–15PubMedCrossRef Hanchanale VS, Javle P (2010) Impact of hospital provider volume on outcome for radical urological cancer surgery in England. Urol Int 85(1):11–15PubMedCrossRef
21.
Zurück zum Zitat Lavery HJ, Brajtbord JS, Levinson AW, Nabizada-Pace F, Pollard ME, Samadi DB (2010) Unnecessary imaging for the staging of low-risk prostate cancer is common. Urology [Epub ahead of print] Lavery HJ, Brajtbord JS, Levinson AW, Nabizada-Pace F, Pollard ME, Samadi DB (2010) Unnecessary imaging for the staging of low-risk prostate cancer is common. Urology [Epub ahead of print]
22.
Zurück zum Zitat Lindenauer PK, Remus D, Roman S, Rothberg MB, Benjamin EM, Ma A, Bratzler DW (2007) Public reporting and pay for performance in hospital quality improvement. N Engl J Med 356(5):486–496PubMedCrossRef Lindenauer PK, Remus D, Roman S, Rothberg MB, Benjamin EM, Ma A, Bratzler DW (2007) Public reporting and pay for performance in hospital quality improvement. N Engl J Med 356(5):486–496PubMedCrossRef
23.
Zurück zum Zitat Madeb R, Golijanin D, Noyes K, Fisher S, Stephenson JJ, Long SR, Knopf J, Lyman GH, Messing EM (2009) Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors. Cancer 115(12):2660–2670PubMedCrossRef Madeb R, Golijanin D, Noyes K, Fisher S, Stephenson JJ, Long SR, Knopf J, Lyman GH, Messing EM (2009) Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors. Cancer 115(12):2660–2670PubMedCrossRef
24.
Zurück zum Zitat Shahinian VB, Kuo YF, Gilbert SM (2010) Reimbursement policy and androgen-deprivation therapy for prostate cancer. N Engl J Med 363(19):1822–1832PubMedCrossRef Shahinian VB, Kuo YF, Gilbert SM (2010) Reimbursement policy and androgen-deprivation therapy for prostate cancer. N Engl J Med 363(19):1822–1832PubMedCrossRef
25.
Zurück zum Zitat Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT (2008) Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358(12):1250–1261PubMedCrossRef Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT (2008) Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358(12):1250–1261PubMedCrossRef
26.
Zurück zum Zitat Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J (1005) Long-term survival among men with conservatively treated localized prostate cancer. JAMA 274(8):626–631CrossRef Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J (1005) Long-term survival among men with conservatively treated localized prostate cancer. JAMA 274(8):626–631CrossRef
27.
Zurück zum Zitat Porter MP, Wei JT, Penson DF (2005) Quality of life issues in bladder cancer patients following cystectomy and urinary diversion. Urol Clin North Am 32(2):207–216PubMedCrossRef Porter MP, Wei JT, Penson DF (2005) Quality of life issues in bladder cancer patients following cystectomy and urinary diversion. Urol Clin North Am 32(2):207–216PubMedCrossRef
28.
Zurück zum Zitat Krupski TL, Saigal CS, Litwin MS (2003) Variation in continence and potency by definition. J Urol 170(4 Pt 1):1291–1294PubMedCrossRef Krupski TL, Saigal CS, Litwin MS (2003) Variation in continence and potency by definition. J Urol 170(4 Pt 1):1291–1294PubMedCrossRef
29.
Zurück zum Zitat Schroeck FR, Krupski TL, Sun L, Albala DM, Price MM, Polascik TJ, Robertson CN, Tewari AK, Moul JW (2008) Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy. Eur Urol 54(4):785–793PubMedCrossRef Schroeck FR, Krupski TL, Sun L, Albala DM, Price MM, Polascik TJ, Robertson CN, Tewari AK, Moul JW (2008) Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy. Eur Urol 54(4):785–793PubMedCrossRef
Metadaten
Titel
Health services research in urology
verfasst von
Hua-yin Yu
William Ulmer
Keith J. Kowalczyk
Jim C. Hu
Publikationsdatum
01.06.2011
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 3/2011
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-011-0657-4

Weitere Artikel der Ausgabe 3/2011

World Journal of Urology 3/2011 Zur Ausgabe

Patrone im Penis bringt Urologen in Gefahr

30.05.2024 Operationen am Penis Nachrichten

In Lebensgefahr brachte ein junger Mann nicht nur sich selbst, sondern auch das urologische Team, das ihm zu Hilfe kam: Er hatte sich zur Selbstbefriedigung eine scharfe Patrone in die Harnröhre gesteckt.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.